Help

Detail
  •  Help
ANTH
Stock ticker:
OTC
51 days until earnings call
Intraday data for
Sep 16, closing price
Price
$0.02
Change
$0.00 (0.00%)
Capitalization
$557.6k

Anthera Pharmaceuticals Inc (ANTH) Stock Forecast, Price, News, Quote

a developer of clinical pharmaceutical products
Industry @Biotechnology
Paper trades
Copy to...
Stock ticker: OTC
ANTH
AS OF
Sep 16, closing price
Price
$0.02
Change
$0.00 (0.00%)
Capitalization
$557.6k
51 days until earnings call

Anthera Pharmaceuticals Inc (ANTH) Stock Forecast, Price, News, Quote

Stock market charts, analyst ratings and a financial calendar

a developer of clinical pharmaceutical products
Industry @Biotechnology
Paper trades
Copy to...
A.I.dvisor
published Commentaries
4:00 PM EDT Sep 16
1W
1M
1Q
6M
1Y
5Y

ANTH: Weekly Commentary

Please wait a moment while the chart loads...
An error occurred while loading prices!
JavaScript chart by amCharts 3.20.5
These past five trading days, the stock gained 4.93% with an average daily volume of 31254 shares traded. The stock tracked a drawdown of -20.1% for this period.
Please wait a moment while the chart loads...
An error occurred while loading prices!
ANTH ANTH scorecard View Buy/Sell Recommendations View Buy/Sell Recommendations
view more
Technical Analysis # Of Indicators Avg. Odds
Bullish trend Bullish trend
Bearish trend Bearish trend
Bearish trend
Bullish trend
Fundamental Analysis (1 - best, 100 - worst)
VIEW HEADLINES VOTE UP or DOWN
A.I.dvisor
published a Summary for ANTH
4:00 PM EDT Sep 16

ANTH's Stochastic Oscillator stays in oversold zone for 7 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Anthera Pharmaceuticals Inc (ANTH) Stock Forecast, Price, News, Quote

Current price $0.02 crossed the support line at $0.04 and is trading between $0.04 support and $0.02 support lines. Throughout the month of 08/16/21 - 09/16/21, the price experienced a -42% Downtrend, while the week of 09/09/21 - 09/16/21 shows a +5% Uptrend.

Technical Analysis, Outlook, Fundamental Analysis READ MORE...
A.I.dvisor
published Earnings Data

ANTH is expected to report earnings to fall 16.36% to -46 cents per share on July 31

Anthera Pharmaceuticals Inc ANTH Stock Earnings Report
Q2'18
Est.
$-0.46
Q1'18
Met
by $-0.55
Q4'17
Missed
by $0.07
The last earnings report on May 14 showed earnings per share of -55 cents, meeting the estimate of -55 cents. With 3.70K shares outstanding, the current market capitalization sits at 557.60K.

Signals about ANTH

Portfolio alert
09/17/21
A.I.dvisor
published Bearish Signal
09/17/21
For the last three days, A.I.dvisor has detected that ANTH's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong downtrend ahead for ANTH, and traders may view it as a Sell signal for the next month. Traders may consider selling the stock or exploring put options. A.I.dvisor backtested this indicator and found 271 similar cases, of which were successful. Based on this data, the odds of success are
LESS
+ Add to portfolio
More...
Less
Portfolio alert
09/16/21
A.I.dvisor
published Bearish Signal
09/16/21
For the last three days, A.I.dvisor has detected that ANTH's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong downtrend ahead for ANTH, and traders may view it as a Sell signal for the next month. Traders may consider selling the stock or exploring put options. A.I.dvisor backtested this indicator and found 271 similar cases, of which were successful. Based on this data, the odds of success are
LESS
+ Add to portfolio
More...
Less
Portfolio alert
09/15/21
A.I.dvisor
published Bearish Signal
09/15/21
For the last three days, A.I.dvisor has detected that ANTH's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong downtrend ahead for ANTH, and traders may view it as a Sell signal for the next month. Traders may consider selling the stock or exploring put options. A.I.dvisor backtested this indicator and found 271 similar cases, of which were successful. Based on this data, the odds of success are
LESS
+ Add to portfolio
More...
Less
Portfolio alert
09/14/21
A.I.dvisor
published Bullish Signal
09/14/21
This is a Bullish indicator signaling ANTH's price could rise from here. Traders may explore going long the stock or buying call options. A.I. dvisor identified 42 similar cases where ANTH's MACD histogram became positive, and of them led to successful outcomes. Odds of Success:
LESS
+ Add to portfolio
More...
Less
Portfolio alert
09/10/21
A.I.dvisor
published Bearish Signal
09/10/21
Anthera Pharmaceuticals (ANTH, $0.02) was a top loser over the last three months, falling -74.47% to $0.02 per share. A.I.dvisor analyzed 603 stocks in the Biotechnology Industry for the 3-month period ending September 9, 2021, and found that 192 of them (31.85%) exhibited an Uptrend while 411 of them (68.15%) demonstrated a Downtrend. 685 similar cases when ANTH's price dropped 15% within three months. In out of those 685 cases, ANTH's price went down during the following month. Based on these historical data, the odds of a Downtrend continuation for ANTH are
LESS
+ Add to portfolio
More...
Less
Portfolio alert
09/09/21
A.I.dvisor
published Bearish Signal
09/09/21
For the last three days, A.I.dvisor has detected that ANTH's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong downtrend ahead for ANTH, and traders may view it as a Sell signal for the next month. Traders may consider selling the stock or exploring put options. A.I.dvisor backtested this indicator and found 271 similar cases, of which were successful. Based on this data, the odds of success are
LESS
+ Add to portfolio
More...
Less
Portfolio alert
09/09/21
A.I.dvisor
published Bearish Signal
09/09/21
This is a Bearish indicator signaling ANTH's price could decline from here. Traders may explore shorting the stock or put options. A.I. dvisor identified 41 similar cases where ANTH's MACD histogram became negative, and of them led to successful outcomes. Odds of Success:
LESS
+ Add to portfolio
More...
Less
Portfolio alert
09/08/21
A.I.dvisor
published Bearish Signal
09/08/21
Anthera Pharmaceuticals (ANTH, $0.02) lost -74.68% over the last three months. By comparison, the broader Biotechnology Industry returned -5.7% over the same period. A.I.dvisor analyzed 612 stocks in the Biotechnology Industry over the last three months, and found that 213 of them (34.86%) exhibited an Uptrend while 399 of them (65.14%) experienced a Downtrend. A.I.dvisor found 685 similar cases when ANTH's price dropped 15% within three months. In out of those 685 cases, ANTH's price went down during the following month. Based on these historical data, A.I. thinks the odds of a Downtrend continuation for ANTH are
LESS
+ Add to portfolio
More...
Less
Portfolio alert
09/08/21
A.I.dvisor
published Bearish Signal
09/08/21
For the last three days, A.I.dvisor has detected that ANTH's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong downtrend ahead for ANTH, and traders may view it as a Sell signal for the next month. Traders may consider selling the stock or exploring put options. A.I.dvisor backtested this indicator and found 271 similar cases, of which were successful. Based on this data, the odds of success are
LESS
+ Add to portfolio
More...
Less
Portfolio alert
09/04/21
A.I.dvisor
published Bearish Signal
09/04/21
For the last three days, A.I.dvisor has detected that ANTH's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong downtrend ahead for ANTH, and traders may view it as a Sell signal for the next month. Traders may consider selling the stock or exploring put options. A.I.dvisor backtested this indicator and found 271 similar cases, of which were successful. Based on this data, the odds of success are
LESS
+ Add to portfolio
More...
Less
Portfolio alert
09/03/21
A.I.dvisor
published Bearish Signal
09/03/21
Anthera Pharmaceuticals (ANTH, $0.02) was a top loser over the last three months, falling -73.58% to $0.02 per share. A.I.dvisor analyzed 613 stocks in the Biotechnology Industry for the 3-month period ending September 2, 2021, and found that 258 of them (42.16%) exhibited an Uptrend while 355 of them (57.84%) demonstrated a Downtrend. 687 similar cases when ANTH's price dropped 15% within three months. In out of those 687 cases, ANTH's price went down during the following month. Based on these historical data, the odds of a Downtrend continuation for ANTH are
LESS
+ Add to portfolio
More...
Less
Portfolio alert
09/03/21
A.I.dvisor
published Bearish Signal
09/03/21
For the last three days, A.I.dvisor has detected that ANTH's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong downtrend ahead for ANTH, and traders may view it as a Sell signal for the next month. Traders may consider selling the stock or exploring put options. A.I.dvisor backtested this indicator and found 271 similar cases, of which were successful. Based on this data, the odds of success are
LESS
+ Add to portfolio
More...
Less
Portfolio alert
09/03/21
A.I.dvisor
published Bullish Signal
09/03/21
This price move could be a signal that ANTH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. A.I.dvisor backtested 49 similar cases where ANTH's price broke its lower Bollinger Band, and of them led to a successful outcome. Odds of Success:
LESS
+ Add to portfolio
More...
Less
Portfolio alert
09/02/21
A.I.dvisor
published Bearish Signal
09/02/21
This indicator may be signaling that ANTH's price has further to drop, since it fell below its price logged 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options. A.I.dvisor backtested 110 similar cases where ANTH's Momentum Indicator fell below the 0 level, and of them led to a successful outcome. Odds of Success:
LESS
+ Add to portfolio
More...
Less
Portfolio alert
09/01/21
A.I.dvisor
published Bullish Signal
09/01/21
Anthera Pharmaceuticals (ANTH, $0.03) was one of the top gainers yesterday, rising +38.89% to $0.03 per share. A.I.dvisor analyzed 613 stocks in the Biotechnology Industry and found that 467 of them (76.18%) are in an Uptrend while 146 of them (23.82%) are in a Downtrend.
LESS
+ Add to portfolio
More...
Less
Portfolio alert
08/31/21
A.I.dvisor
published Bearish Signal
08/31/21
Anthera Pharmaceuticals (ANTH, $0.02) lost -70.81% over the last three months. By comparison, the broader Biotechnology Industry returned -3.59% over the same period. A.I.dvisor analyzed 612 stocks in the Biotechnology Industry over the last three months, and found that 229 of them (37.44%) exhibited an Uptrend while 383 of them (62.56%) experienced a Downtrend. A.I.dvisor found 689 similar cases when ANTH's price dropped 15% within three months. In out of those 689 cases, ANTH's price went down during the following month. Based on these historical data, A.I. thinks the odds of a Downtrend continuation for ANTH are
LESS
+ Add to portfolio
More...
Less
Portfolio alert
08/31/21
A.I.dvisor
published Bullish Signal
08/31/21
This price move could be a signal that ANTH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. A.I.dvisor backtested 49 similar cases where ANTH's price broke its lower Bollinger Band, and of them led to a successful outcome. Odds of Success:
LESS
+ Add to portfolio
More...
Less
Portfolio alert
08/31/21
A.I.dvisor
published Bearish Signal
08/31/21
This indicator may be signaling that ANTH's price has further to drop, since it fell below its price logged 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options. A.I.dvisor backtested 110 similar cases where ANTH's Momentum Indicator fell below the 0 level, and of them led to a successful outcome. Odds of Success:
LESS
+ Add to portfolio
More...
Less
Portfolio alert
08/27/21
A.I.dvisor
published Bearish Signal
08/27/21
Anthera Pharmaceuticals (ANTH, $0.03) was a top loser over the last three months, falling -64.56% to $0.03 per share. A.I.dvisor analyzed 612 stocks in the Biotechnology Industry for the 3-month period ending August 26, 2021, and found that 227 of them (37.1%) exhibited an Uptrend while 385 of them (62.9%) demonstrated a Downtrend.
LESS
+ Add to portfolio
More...
Less
Portfolio alert
08/25/21
A.I.dvisor
published Bearish Signal
08/25/21
This indicator may be signaling that ANTH's price has further to drop, since it fell below its price logged 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options. A.I.dvisor backtested 110 similar cases where ANTH's Momentum Indicator fell below the 0 level, and of them led to a successful outcome. Odds of Success:
LESS
+ Add to portfolio
More...
Less
Industry Highlights
MORE...
Contact us
About us
Membership
Affiliate Program
Press Releases
FAQ
Legal information
Report a problem
FREE E-BOOKS:
Pattern Search Engine eBook
Trend Prediction Engine eBook
#Stochastics and #RSI: A Trader's Guide
How to Use Moving Averages In Trading?
Getting the Most Out of Your 401(k)
5 Key Fundamentals for Trading Success
© 2013-2021 All rights reserved. Tickeron Inc.

Contact us
About us
Membership
Affiliate Program
Press Releases
FAQ
Report a problem
Legal information

FREE E-BOOKS:
Pattern Search Engine eBook
Trend Prediction Engine eBook
#Stochastics and #RSI: A Trader's Guide
How to Use Moving Averages In Trading?
Getting the Most Out of Your 401(k)
5 Key Fundamentals for Trading Success
© 2013-2021 All rights reserved. Tickeron Inc.

Log out

Do you want to log out?